chr2-201289477-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001127391.3(FLACC1):​c.1122G>A​(p.Thr374Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 1,613,772 control chromosomes in the GnomAD database, including 11,968 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.097 ( 810 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11158 hom. )

Consequence

FLACC1
NM_001127391.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.573

Publications

56 publications found
Variant links:
Genes affected
FLACC1 (HGNC:14439): (flagellum associated containing coiled-coil domains 1) Predicted to be located in cytoplasmic vesicle and sperm flagellum. Predicted to be active in cytoplasm; outer dense fiber; and sperm fibrous sheath. [provided by Alliance of Genome Resources, Apr 2022]
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-201289477-C-T is Benign according to our data. Variant chr2-201289477-C-T is described in ClinVar as Benign. ClinVar VariationId is 402494.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.573 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127391.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLACC1
NM_001127391.3
MANE Select
c.1122G>Ap.Thr374Thr
synonymous
Exon 14 of 15NP_001120863.1Q96Q35-2
FLACC1
NM_139163.4
c.1191G>Ap.Thr397Thr
synonymous
Exon 14 of 15NP_631902.2Q96Q35-1
FLACC1
NM_001289993.2
c.1122G>Ap.Thr374Thr
synonymous
Exon 14 of 15NP_001276922.1Q96Q35-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLACC1
ENST00000392257.8
TSL:1 MANE Select
c.1122G>Ap.Thr374Thr
synonymous
Exon 14 of 15ENSP00000376086.3Q96Q35-2
FLACC1
ENST00000286190.9
TSL:1
c.1191G>Ap.Thr397Thr
synonymous
Exon 13 of 14ENSP00000286190.5Q96Q35-1
FLACC1
ENST00000405148.6
TSL:5
c.1191G>Ap.Thr397Thr
synonymous
Exon 14 of 15ENSP00000385098.2Q96Q35-1

Frequencies

GnomAD3 genomes
AF:
0.0967
AC:
14711
AN:
152154
Hom.:
808
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0622
Gnomad AMI
AF:
0.271
Gnomad AMR
AF:
0.0864
Gnomad ASJ
AF:
0.0637
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.0381
Gnomad FIN
AF:
0.0979
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.130
Gnomad OTH
AF:
0.108
GnomAD2 exomes
AF:
0.0896
AC:
22515
AN:
251398
AF XY:
0.0891
show subpopulations
Gnomad AFR exome
AF:
0.0615
Gnomad AMR exome
AF:
0.0571
Gnomad ASJ exome
AF:
0.0606
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.103
Gnomad NFE exome
AF:
0.129
Gnomad OTH exome
AF:
0.105
GnomAD4 exome
AF:
0.117
AC:
171047
AN:
1461500
Hom.:
11158
Cov.:
32
AF XY:
0.115
AC XY:
83650
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.0577
AC:
1931
AN:
33478
American (AMR)
AF:
0.0601
AC:
2689
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0646
AC:
1687
AN:
26132
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39700
South Asian (SAS)
AF:
0.0467
AC:
4028
AN:
86240
European-Finnish (FIN)
AF:
0.106
AC:
5655
AN:
53402
Middle Eastern (MID)
AF:
0.0836
AC:
482
AN:
5766
European-Non Finnish (NFE)
AF:
0.133
AC:
147978
AN:
1111684
Other (OTH)
AF:
0.109
AC:
6589
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
7252
14503
21755
29006
36258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5134
10268
15402
20536
25670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0968
AC:
14733
AN:
152272
Hom.:
810
Cov.:
32
AF XY:
0.0932
AC XY:
6942
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0627
AC:
2606
AN:
41548
American (AMR)
AF:
0.0862
AC:
1318
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0637
AC:
221
AN:
3472
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5192
South Asian (SAS)
AF:
0.0385
AC:
186
AN:
4826
European-Finnish (FIN)
AF:
0.0979
AC:
1038
AN:
10606
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.130
AC:
8870
AN:
68022
Other (OTH)
AF:
0.107
AC:
225
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
684
1368
2051
2735
3419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.118
Hom.:
2256
Bravo
AF:
0.0947
Asia WGS
AF:
0.0270
AC:
94
AN:
3478
EpiCase
AF:
0.129
EpiControl
AF:
0.125

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
1.1
DANN
Benign
0.65
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17468277; hg19: chr2-202154200; COSMIC: COSV51860617; COSMIC: COSV51860617; API